Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-13003884Phase 4Completed
Phase 4, randomised, open-label trial of kangai injection in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoints: Disease control rate, Response rate and 1 more. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-13003884.